MarineMax, Inc. (HZO)
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-10-29
$52.59+0.17%
Close 2026-10-29 · 1-day change
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-10-29
Research Workspace
Put HZO beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Inventory <= $845.4M and floor plan borrowings <= $689.9M in Q2 2026: Direct metric needs a verified mapping.
View ThesisRevenue is contracting — down about 5% over the past year.
View GrowthManagement screens weak on capital allocation, earnings delivery.
View ManagementExpectations look high — the market is pricing in about 16% growth a year, above the roughly 5% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 0% a day.
View RiskHZO’s investment case depends on revenue stabilizing after recent contraction, with cash backing reported profits. Q3 FY2026 revenue fell 7% year over year, and earnings were inline. HZO trades at 0.6× sales versus a 0.8× peer median; expectations look full. Its 0.6× sales multiple also exceeds its 0.4× historical multiple. The next-quarter miss probability is 39%, and reported profits are not well backed by cash. The inventory and floor-plan borrowing pillar needs verified mapping, so its status remains uncertain. Peer multiples imply a price about 16% below where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-29. HZO is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 10 analysts currently covering HZO (as of Oct 2026).
Based on 3 Wall Street analysts offering 12-month price targets for HZO in the last 4 months.
Continue this research
Compare HZO with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| HZO Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 6 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Consumer Discretionary (broad) — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put HZO next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Potential acquisition could enhance growth and capital allocation.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $52.59
The last 12 months of price, then the range of analyst 12-month targets from today’s $52.59.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Partnership expansion aligns with growth objectives and revenue guidance.
Takeover could enhance growth and margin objectives.